The Role of Molecular Diagnostics in Cervical Cancer Prevention & Management

This webinar explores the critical transition from traditional cytology to Molecular Diagnostics in the fight against cervical cancer, specifically within the Indian healthcare landscape. With high-risk genotypes HPV 16 and 18 accounting for over 85% of cases in India, the need for high-sensitivity.